Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04181723
Recruitment Status : Recruiting
First Posted : November 29, 2019
Last Update Posted : May 12, 2021
Sponsor:
Information provided by (Responsible Party):
ACADIA Pharmaceuticals Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : October 2021